Your browser doesn't support javascript.
loading
PPT1 Promotes Tumor Growth and Is the Molecular Target of Chloroquine Derivatives in Cancer.
Rebecca, Vito W; Nicastri, Michael C; Fennelly, Colin; Chude, Cynthia I; Barber-Rotenberg, Julie S; Ronghe, Amruta; McAfee, Quentin; McLaughlin, Noel P; Zhang, Gao; Goldman, Aaron R; Ojha, Rani; Piao, Shengfu; Noguera-Ortega, Estela; Martorella, Alessandra; Alicea, Gretchen M; Lee, Jennifer J; Schuchter, Lynn M; Xu, Xiaowei; Herlyn, Meenhard; Marmorstein, Ronen; Gimotty, Phyllis A; Speicher, David W; Winkler, Jeffrey D; Amaravadi, Ravi K.
Afiliación
  • Rebecca VW; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Nicastri MC; Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Fennelly C; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Chude CI; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Barber-Rotenberg JS; Department of Biochemistry and Biophysics, Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Ronghe A; Molecular and Cellular Oncogenesis Program and Melanoma Research Center, Wistar Institute, Philadelphia, Pennsylvania.
  • McAfee Q; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • McLaughlin NP; Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Zhang G; Molecular and Cellular Oncogenesis Program and Melanoma Research Center, Wistar Institute, Philadelphia, Pennsylvania.
  • Goldman AR; Molecular and Cellular Oncogenesis Program and Melanoma Research Center, Wistar Institute, Philadelphia, Pennsylvania.
  • Ojha R; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Piao S; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Noguera-Ortega E; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Martorella A; Molecular and Cellular Oncogenesis Program and Melanoma Research Center, Wistar Institute, Philadelphia, Pennsylvania.
  • Alicea GM; Molecular and Cellular Oncogenesis Program and Melanoma Research Center, Wistar Institute, Philadelphia, Pennsylvania.
  • Lee JJ; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Schuchter LM; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Xu X; Department of Pathology, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Herlyn M; Molecular and Cellular Oncogenesis Program and Melanoma Research Center, Wistar Institute, Philadelphia, Pennsylvania.
  • Marmorstein R; Department of Biochemistry and Biophysics, Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Gimotty PA; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Speicher DW; Molecular and Cellular Oncogenesis Program and Melanoma Research Center, Wistar Institute, Philadelphia, Pennsylvania.
  • Winkler JD; Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania. Winkler@sas.upenn.edu Ravi.amaravadi@uphs.upenn.edu.
  • Amaravadi RK; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Winkler@sas.upenn.edu Ravi.amaravadi@uphs.upenn.edu.
Cancer Discov ; 9(2): 220-229, 2019 02.
Article en En | MEDLINE | ID: mdl-30442709
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tioléster Hidrolasas / Biomarcadores de Tumor / Cloroquina / Proteínas de la Membrana / Neoplasias / Antimaláricos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Discov Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Tioléster Hidrolasas / Biomarcadores de Tumor / Cloroquina / Proteínas de la Membrana / Neoplasias / Antimaláricos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Discov Año: 2019 Tipo del documento: Article